UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The potential of SOCTA as a chelator for radiolabeling of trastuzumab with 99mTc

Journal of radioanalytical and nuclear chemistry, 2016-02, Vol.307 (2), p.1353-1357

2016

Volltextzugriff (PDF)

The potential of SOCTA as a chelator for radiolabeling of trastuzumab with .sup.99mTc

Journal of radioanalytical and nuclear chemistry, 2016-02, Vol.307 (2), p.1353

2016

Volltextzugriff (PDF)

SU‐FF‐I‐49: The Effects of Magnetic Field On Energy Resolution and Linearity in SPECT System

Medical physics (Lancaster), 2005-06, Vol.32 (6), p.1915-1915

2005

Volltextzugriff (PDF)

P22 A fast method for calculation of non-uniformity in nuclear medicine images by Fourier transformation in low count density

Nuclear medicine communications, 2006-03, Vol.27 (3), p.304

2006

Volltextzugriff (PDF)

A New Structure and Routing Algorithm for Optimizing Energy Consumption in Wireless Sensor Network for Disaster Management

2013 4th International Conference on Intelligent Systems, Modelling and Simulation, 2013, p.481-485

2013

Volltextzugriff (PDF)

A QoS Aware Learning Automata Based Channel Assignment Method in Cognitive Network

Wireless personal communications, 2017-11, Vol.97 (1), p.495-519

2017

Volltextzugriff (PDF)

Monitoring magma migration at Mt. Etna using the Seismic Amplitude Ratio Analysis method

Annals of geophysics, 2022-07, Vol.65 (Vol. 65 (2022))

2022

Volltextzugriff (PDF)

Development and validation of a novel panel of 16 STR markers for simultaneous diagnosis of β-thalassemia, aneuploidy screening, maternal cell contamination detection and fetal sample authenticity in PND and PGD/PGS cases

Scientific reports, 2019-05, Vol.9 (1), p.7452-7452, Article 7452

2019

Volltextzugriff (PDF)

Activity estimation in radioimmunotherapy using magnetic nanoparticles

Chinese journal of cancer research, 2015-04, Vol.27 (2), p.203-208

2015

Volltextzugriff (PDF)

The possibility of using magnetic nanoparticles to increase the therapeutic efficiency of Herceptin antibody

Biomedizinische Technik, 2015-10, Vol.60 (5), p.485

2015

Volltextzugriff (PDF)

MRI contrast agent for molecular imaging of the HER2/neu receptor using targeted magnetic nanoparticles

Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology, 2011-06, Vol.13 (6), p.2285-2293

2011

Volltextzugriff (PDF)

Development of DOTA-Rituximab to be Labeled with 90 Y for Radioimmunotherapy of B-cell Non-Hodgkin Lymphoma

Iranian journal of pharmaceutical research : IJPR, 2017, Vol.16 (2), p.619

2017

Volltextzugriff (PDF)

Development of DOTA-Rituximab to be Labeled with 90Y for Radioimmunotherapy of B-cell Non-Hodgkin Lymphoma

Iranian journal of pharmaceutical research : IJPR, 2017-01, Vol.16 (2), p.619-629

2017

Volltextzugriff (PDF)

Verification of Activity Accumulation Location Effect in Patients Treated with I-131 Radio Pharmacy on the Evaluated Exposure at Different Distances from Patient using NCAT Phantom

Majallah-i ʻilmī-i Dānishgāh-i ʻUlūm-i Pizishkī-i Īlām, 2018-03, Vol.25 (6), p.54-62

2018

Volltextzugriff (PDF)

Radioimmunotherapy of mice bearing breast tumors with ^{177}Lu-labeled trastuzumab

Turkish Journal of Medical Sciences, 2012-01

2012

Volltextzugriff (PDF)

super(177)Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer

Nuclear medicine and biology, 2010-11, Vol.37 (8), p.949-955

2010

Volltextzugriff (PDF)

Toxicity of trastuzumab labeled 177Lu on MCF7 and SKBr3 cell lines

Applied radiation and isotopes, 2010-10, Vol.68 (10), p.1964-1966

2010

Volltextzugriff (PDF)

177 Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer

Nuclear medicine and biology, 2010, Vol.37 (8), p.949-955

2010

Volltextzugriff (PDF)

177Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer

Nuclear medicine and biology, 2010-11, Vol.37 (8), p.949-955

2010

Volltextzugriff (PDF)

Radioimmunotherapy of mice bearing breast tumors with 177Lu-labeled trastuzumab

Turkish journal of medical sciences, 2011-12

2011

Volltextzugriff (PDF)

Synthesis and biodistribution studiesof 177Lu-trastuzumab as a therapeutic agent in the breast cancer mice model

Journal of labelled compounds & radiopharmaceuticals, 2010-07, Vol.53 (9), p.575-579

2010

Volltextzugriff (PDF)

Synthesis and biodistribution studiesof 177 Lu‐trastuzumab as a therapeutic agent in the breast cancer mice model

Journal of labelled compounds & radiopharmaceuticals, 2010-07, Vol.53 (9), p.575-579

2010

Volltextzugriff (PDF)

Synthesis and biodistribution studies of 177Lu-trastuzumab as a therapeutic agent in the breast cancer mice model

Journal of labelled compounds & radiopharmaceuticals, 2010, Vol.53 (9-10), p.575-579

2010

Volltextzugriff (PDF)

Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer

Nuclear medicine and biology, 2009-05, Vol.36 (4), p.363-369

2009

Volltextzugriff (PDF)

Radiolabeling of trastuzumab with super(177)Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer

Nuclear medicine and biology, 2009-05, Vol.36 (4), p.363-369

2009

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)
Tagungsberichte
(1)

Sprache

Englisch
(31)
Persisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(7)
Trastuzumab
(7)
Lutetium-177
(6)
Breast Cancer
(5)
Radioimmunotherapy
(5)
Cell Line, Tumor
(4)
Herceptin
(4)
Mice
(4)
Technology
(4)
Antibodies, Monoclonal, Humanized
(3)
Breast Neoplasms - Pathology
(3)
Breast Neoplasms - Radiotherapy
(3)
Dota
(3)
Female
(3)
Humans
(3)
Nanoparticles
(3)
Tumors
(3)
Animals
(2)
Antibodies, Monoclonal - Pharmacology
(2)
Antibodies, Monoclonal - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The potential of SOCTA as a chelator for radiolabeling of trastuzumab with 99mTc

The potential of SOCTA as a chelator for radiolabeling of trastuzumab with .sup.99mTc

SU‐FF‐I‐49: The Effects of Magnetic Field On Energy Resolution and Linearity in SPECT System

P22 A fast method for calculation of non-uniformity in nuclear medicine images by Fourier transformation in low count density

A New Structure and Routing Algorithm for Optimizing Energy Consumption in Wireless Sensor Network for Disaster Management

A QoS Aware Learning Automata Based Channel Assignment Method in Cognitive Network

Monitoring magma migration at Mt. Etna using the Seismic Amplitude Ratio Analysis method

Development and validation of a novel panel of 16 STR markers for simultaneous diagnosis of β-thalassemia, aneuploidy screening, maternal cell contamination detection and fetal sample authenticity in PND and PGD/PGS cases

Activity estimation in radioimmunotherapy using magnetic nanoparticles

The possibility of using magnetic nanoparticles to increase the therapeutic efficiency of Herceptin antibody

MRI contrast agent for molecular imaging of the HER2/neu receptor using targeted magnetic nanoparticles

Development of DOTA-Rituximab to be Labeled with 90 Y for Radioimmunotherapy of B-cell Non-Hodgkin Lymphoma

Development of DOTA-Rituximab to be Labeled with 90Y for Radioimmunotherapy of B-cell Non-Hodgkin Lymphoma

Verification of Activity Accumulation Location Effect in Patients Treated with I-131 Radio Pharmacy on the Evaluated Exposure at Different Distances from Patient using NCAT Phantom

Radioimmunotherapy of mice bearing breast tumors with ^{177}Lu-labeled trastuzumab

super(177)Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer

Toxicity of trastuzumab labeled 177Lu on MCF7 and SKBr3 cell lines

177 Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer

177Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer

Radioimmunotherapy of mice bearing breast tumors with 177Lu-labeled trastuzumab

Synthesis and biodistribution studiesof 177Lu-trastuzumab as a therapeutic agent in the breast cancer mice model

Synthesis and biodistribution studiesof 177 Lu‐trastuzumab as a therapeutic agent in the breast cancer mice model

Synthesis and biodistribution studies of 177Lu-trastuzumab as a therapeutic agent in the breast cancer mice model

Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer

Radiolabeling of trastuzumab with super(177)Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer

Suchergebnisse filtern